Bhuvana A Setty

Contact Information

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Bhuvana A. Setty

Biography

Bhuvana Setty, MD, is a Pediatric Hematologist/Oncologist at Nationwide Children’s Hospital. Her clinical interests include treating pediatric and young adult patients with bone and soft tissue sarcomas, and patients with vascular anomalies. She is the Director of the Clinical Sarcoma Team, an active member of the Hemangioma and Vascular Malformations Team, and the Lymphatic Imaging and Intervention Program. She is the Site Principal Investigator for The Sunshine Project, an early phase clinical trial consortium and CaNVAS, the Consortium of iNvestigators for Vascular Anomalies. Her research interests include developing translational and therapeutic clinical trials with novel agents for patients with aggressive bone and soft tissue sarcomas, and for patients with complex vascular anomalies.

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Languages Spoken

English Hindi Kannada

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Hematology, Oncology and BMT Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Awards, Honors & Organizations

Outstanding Clinical-Translational Investigator Award, Hematology/Oncology/BMT, Nationwide Children’s Hospital, 2020 Faculty Professionalism Award, Hematology/Oncology/BMT, Nationwide Children’s Hospital, 2019 Commendation for Capstone Project Proposal, Harvard Medical School, 2014 Member, American Society of Clinical Oncology, 2018 - Present Member, International Society for the Study of Vascular Anomalies, 2018 - Present Member, Connective Tissue Oncology Society, 2010 - Present Member, Children’s Oncology Group, 2009 - Present Member, American Society of Pediatric Hematology/Oncology, 2008 - Present

Research

Interests

Complex Vascular Malformations Ewing Sarcoma Osteosarcoma Rhabdomyosarcoma

Publications

                  Abdelbaki MS, DeWire Schottmiller MD, Cripe TP, Curry RC, Cruze CA, Her L, Demko S, Casey D, Setty B. An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumors. Heliyon. 2022 Dec; 8: e12450.

                


                  Hou YC, Evenson MJ, Corliss MM, Mahapatra L, Aldawood A, Carpentieri DF, Chamlin SL, Kulungowski AM, Madan-Khetarpal S, Sebastian J, Pet MA, Coughlin CC, Willing MC, Pearson GD, Setty BA, El-Haffaf Z, Cottrell CE, Parikh BA, Krysiak K, Schroeder MC, Heusel JW, Neidich JA, Cao Y. A Comparative Analysis of RAS Variants in Patients with Disorders of Somatic Mosaicism. Genet Med. 2022 Nov 29;  

                


                  Setty BA, Wusik K, Hammill AM. How we approach genetics in the diagnosis and management of vascular anomalies. Pediatr Blood Cancer. 2022 Aug; 69 Suppl 3: e29320.

                


                  Koo SC, Schieffer KM, Lee K, Gupta A, Pfau RB, Avenarius MR, Stonerock E, LaHaye S, Fitch J, Setty BA, Roberts R, Ranalli M, Conces MR, Bu F, Mardis ER, Cottrell CE. EGFR internal tandem duplications in fusion-negative congenital and neonatal spindle cell tumors. Genes Chromosomes Cancer. 2022 Jul 7;  

                


                  de Souza Fernandez Pereira M, Carr DR, Gatti-Mays ME, Olsen MR, Setty BA, Shahwan KT, Lee DA. Natural Killer Cell Recognition and Control of Epithelial Cancers. Cancer J. 2022 Jul-Aug 01; 28: 263-269.

                


                  Pearson AD, Gaspar N, Janeway K, Campbell-Hewson Q, Lawlor ER, Copland C, Karres D, Norga K, Benzaghou F, Weiner S, Weigel B, Weiss AR, Strauss SJ, Smith M, Setty BA, Seibel N, Scobie N, Pappo A, Okpara CE, Nysom K, McDonough J, Marshall LV, Ludwinski D, Ligas F, Lesa G, Knudsen S, Kauh J, Hsieh A, Heenen D, Hawkins DS, Graham A, Garmey E, DuBois SG, Fox E, Donoghue M, de Rojas T, Chung J, Casanova M, Brennan B, Bishop M, Buenger V, Reaman G, Vassal G. Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. Eur J Cancer. 2022 Jul 18; 173: 71-90.

                


                  Fetzko S, Fonseca A, Frances Wedekind M, Gupta AA, Setty BA, Schraw J, Lupo PJ, Guillerman RP, Butala AA, Russell H, Nicholls L, Walterhouse D, Hawkins DS, Okcu MF. Is Detection of Relapse by Surveillance Imaging Associated With Longer Survival in Patients With Rhabdomyosarcoma? J Pediatr Hematol Oncol. 2022 Feb 9;  

                


                  Baliga S, Matsui J, Klamer B, Cetnar A, Ewing A, Cadieux C, Gupta A, Setty BA, Roberts RD, Olshefski RS, Cripe TP, Scharschmidt TJ, Aldrink J, Mardis E, Yeager ND, Palmer JD. Clinical outcomes and efficacy of stereotactic body radiation therapy in children, adolescents, and young adults with metastatic solid tumors. Br J Radiol. 2022 Feb 10;  20211088.

                


                  Halsey JN, Faith EF, Logan SJ, Shenoy A, Schieffer KM, Cottrell CE, Lillis AP, Aldrink JH, Setty BA, Pearson GD. Syringocystadenocarcinoma Papilliferum in a Fifteen-Year-Old Girl: A Case Report and Review of the Literature. Case Rep Dermatol Med. 2022; 2022: 8076649.

                


                  Merjaneh N, Young J, Mangoli A, Olsen M, Setty B, Lane A, Nagarajan R, Pressey JG, Turpin B. Chemotherapy-induced thrombocytopenia in Ewing sarcoma: Implications and potential for romiplostim supportive care. Pediatr Blood Cancer. 2021 Dec 28;  e29548.

                


                  LaHaye S, Fitch JR, Voytovich KJ, Herman AC, Kelly BJ, Lammi GE, Arbesfeld JA, Wijeratne S, Franklin SJ, Schieffer KM, Bir N, McGrath SD, Miller AR, Wetzel A, Miller KE, Bedrosian TA, Leraas K, Varga EA, Lee K, Gupta A, Setty B, Boué DR, Leonard JR, Finlay JL, Abdelbaki MS, Osorio DS, Koo SC, Koboldt DC, Wagner AH, Eisfeld AK, Mrózek K, Magrini V, Cottrell CE, Mardis ER, Wilson RK, White P. Discovery of clinically relevant fusions in pediatric cancer. BMC Genomics. 2021 Dec 4; 22: 872.

                


                  Perisa MP, Stanek J, Setty BA, Nicol K, Yeager N. Evaluating Age-related Disparity of Outcomes in Ewing Sarcoma Patients Treated at a Pediatric Academic Medical Center. J Pediatr Hematol Oncol. 2021 Jul 1; 43: e702-e706.

                


                  Osman AF, Setty BA. Case 3: Abdominal Distention, Shock, and Neonatal Encephalopathy. Neoreviews. 2021 Jun; 22: e406-e408.

                


                  Orr A, Liu H, Mariani R, Aldrink JH, Setty BA, Koo S. Bilateral Lung Metastases From a Phalangeal Giant Cell Tumor of Bone. Pediatr Dev Pathol. 2021 Jan-Feb; 24: 51-55.

                


                  Gupta A, Belsky JA, Schieffer KM, Leraas K, Varga E, McGrath SD, Koo SC, Magrini V, Wilson RK, White P, Mardis ER, Jatana KR, Cottrell CE, Setty BA. Infantile fibrosarcoma-like tumor driven by novel RBPMS-MET fusion consolidated with cabozantinib. Cold Spring Harb Mol Case Stud. 2020 Oct; 6: 

                


                  Belsky JA, Wolf K, Setty BA. A Case of Resolved Vincristine-Induced Constipation Following Osteopathic Medicine in a Patient With Infantile Fibrosarcoma. J Am Osteopath Assoc. 2020 Oct 1; 120: 691-695.

                


                  Oesterheld JE, Reed DR, Setty BA, Isakoff MS, Thompson P, Yin H, Hayashi M, Loeb DM, Smith T, Makanji R, Fridley BL, Wagner LM. Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation. Pediatr Blood Cancer. 2020 Jul; 67: e28370.

                


                  Setty BA, Jinesh GG, Arnold M, Pettersson F, Cheng CH, Cen L, Yoder SJ, Teer JK, Flores ER, Reed DR, Brohl AS. The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss. PLoS Genet. 2020 Apr; 16: e1008642.

                


                  Charan M, Dravid P, Cam M, Setty B, Roberts RD, Houghton PJ, Cam H. Tumor secreted ANGPTL2 facilitates recruitment of neutrophils to the lung to promote lung pre-metastatic niche formation and targeting ANGPTL2 signaling affects metastatic disease. Oncotarget. 2020 Feb 4; 11: 510-522.

                


                  Tullius BP, Setty BA, Lee DA. Natural Killer Cell Immunotherapy for Osteosarcoma. Adv Exp Med Biol. 2020; 1257: 141-154.

                


                  Streby KA, Currier MA, Triplet M, Ott K, Dishman DJ, Vaughan MR, Ranalli MA, Setty B, Skeens MA, Whiteside S, Yeager ND, Haworth KB, Simpson K, Conner J, Cripe TP. First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial. Mol Ther. 2019 Nov 6; 27: 1930-1938.

                


                  Patel P, Roberts R, Cole J, Stalling M, Nicol K, Hor K, Bowman J, Setty B. A Rare Case of an Intracardiac Myoepithelial Carcinoma in an Infant. J Pediatr Hematol Oncol. 2019 May; 41: e206-e209.

                


                  Shah N, Scharschmidt T, Fung B, Conces M, Setty BA. Aneursymal Bone Cyst: An Uncommon Paraspinal Tumor in Children. J Pediatr Hematol Oncol. 2019 Mar; 41: e129-e131.

                


                  Trucco M, Barredo JC, Goldberg J, Leclerc GM, Hale GA, Gill J, Setty B, Smith T, Lush R, Lee JK, Reed DR. A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG-asparaginase, and doxorubicin. Pediatr Blood Cancer. 2018 Sep; 65: e27224.

                


                  Setty BA, Stanek JR, Mascarenhas L, Miller A, Bagatell R, Okcu F, Nicholls L, Lysecki D, Gupta AA. VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma. Pediatr Blood Cancer. 2018 Jan; 65: 

                


                  Jacobson AE, Shah N, Setty BA. Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. Pediatr Blood Cancer. 2017 Aug; 64: 

                


                  Setty BA, Pillay Smiley N, Pool CM, Jin Y, Liu Y, Nelin LD. Hypoxia-induced proliferation of HeLa cells depends on epidermal growth factor receptor-mediated arginase II induction. Physiol Rep. 2017 Mar; 5: 

                


                  Audino AN, Setty BA, Yeager ND. Rhabdomyosarcoma of the Breast in Adolescent and Young Adult (AYA) Women. J Pediatr Hematol Oncol. 2017 Jan; 39: 62-66.

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 01/28/2011

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2011

Residency

University of Illinois Medical Center at Chicago

Date Completed: 06/30/2008

Medical School

BLDEA’s Shri B M Patil Medical College

Date Completed: 08/30/2003

Clinical Interests

Complex Vascular Anomalies Ewing Sarcoma Lymphatic Malformations Non Rhabdomyosarcoma Soft Tissue Tumors Osteosarcoma Rhabdomyosarcoma Venous Malformations

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Bhuvana A. Setty

Biography

Bhuvana Setty, MD, is a Pediatric Hematologist/Oncologist at Nationwide Children’s Hospital. Her clinical interests include treating pediatric and young adult patients with bone and soft tissue sarcomas, and patients with vascular anomalies. She is the Director of the Clinical Sarcoma Team, an active member of the Hemangioma and Vascular Malformations Team, and the Lymphatic Imaging and Intervention Program. She is the Site Principal Investigator for The Sunshine Project, an early phase clinical trial consortium and CaNVAS, the Consortium of iNvestigators for Vascular Anomalies. Her research interests include developing translational and therapeutic clinical trials with novel agents for patients with aggressive bone and soft tissue sarcomas, and for patients with complex vascular anomalies.

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Languages Spoken

English Hindi Kannada

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Hematology, Oncology and BMT Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Awards, Honors & Organizations

Outstanding Clinical-Translational Investigator Award, Hematology/Oncology/BMT, Nationwide Children’s Hospital, 2020 Faculty Professionalism Award, Hematology/Oncology/BMT, Nationwide Children’s Hospital, 2019 Commendation for Capstone Project Proposal, Harvard Medical School, 2014 Member, American Society of Clinical Oncology, 2018 - Present Member, International Society for the Study of Vascular Anomalies, 2018 - Present Member, Connective Tissue Oncology Society, 2010 - Present Member, Children’s Oncology Group, 2009 - Present Member, American Society of Pediatric Hematology/Oncology, 2008 - Present

Research

Interests

Complex Vascular Malformations Ewing Sarcoma Osteosarcoma Rhabdomyosarcoma

Publications

                  Abdelbaki MS, DeWire Schottmiller MD, Cripe TP, Curry RC, Cruze CA, Her L, Demko S, Casey D, Setty B. An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumors. Heliyon. 2022 Dec; 8: e12450.

                


                  Hou YC, Evenson MJ, Corliss MM, Mahapatra L, Aldawood A, Carpentieri DF, Chamlin SL, Kulungowski AM, Madan-Khetarpal S, Sebastian J, Pet MA, Coughlin CC, Willing MC, Pearson GD, Setty BA, El-Haffaf Z, Cottrell CE, Parikh BA, Krysiak K, Schroeder MC, Heusel JW, Neidich JA, Cao Y. A Comparative Analysis of RAS Variants in Patients with Disorders of Somatic Mosaicism. Genet Med. 2022 Nov 29;  

                


                  Setty BA, Wusik K, Hammill AM. How we approach genetics in the diagnosis and management of vascular anomalies. Pediatr Blood Cancer. 2022 Aug; 69 Suppl 3: e29320.

                


                  Koo SC, Schieffer KM, Lee K, Gupta A, Pfau RB, Avenarius MR, Stonerock E, LaHaye S, Fitch J, Setty BA, Roberts R, Ranalli M, Conces MR, Bu F, Mardis ER, Cottrell CE. EGFR internal tandem duplications in fusion-negative congenital and neonatal spindle cell tumors. Genes Chromosomes Cancer. 2022 Jul 7;  

                


                  de Souza Fernandez Pereira M, Carr DR, Gatti-Mays ME, Olsen MR, Setty BA, Shahwan KT, Lee DA. Natural Killer Cell Recognition and Control of Epithelial Cancers. Cancer J. 2022 Jul-Aug 01; 28: 263-269.

                


                  Pearson AD, Gaspar N, Janeway K, Campbell-Hewson Q, Lawlor ER, Copland C, Karres D, Norga K, Benzaghou F, Weiner S, Weigel B, Weiss AR, Strauss SJ, Smith M, Setty BA, Seibel N, Scobie N, Pappo A, Okpara CE, Nysom K, McDonough J, Marshall LV, Ludwinski D, Ligas F, Lesa G, Knudsen S, Kauh J, Hsieh A, Heenen D, Hawkins DS, Graham A, Garmey E, DuBois SG, Fox E, Donoghue M, de Rojas T, Chung J, Casanova M, Brennan B, Bishop M, Buenger V, Reaman G, Vassal G. Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. Eur J Cancer. 2022 Jul 18; 173: 71-90.

                


                  Fetzko S, Fonseca A, Frances Wedekind M, Gupta AA, Setty BA, Schraw J, Lupo PJ, Guillerman RP, Butala AA, Russell H, Nicholls L, Walterhouse D, Hawkins DS, Okcu MF. Is Detection of Relapse by Surveillance Imaging Associated With Longer Survival in Patients With Rhabdomyosarcoma? J Pediatr Hematol Oncol. 2022 Feb 9;  

                


                  Baliga S, Matsui J, Klamer B, Cetnar A, Ewing A, Cadieux C, Gupta A, Setty BA, Roberts RD, Olshefski RS, Cripe TP, Scharschmidt TJ, Aldrink J, Mardis E, Yeager ND, Palmer JD. Clinical outcomes and efficacy of stereotactic body radiation therapy in children, adolescents, and young adults with metastatic solid tumors. Br J Radiol. 2022 Feb 10;  20211088.

                


                  Halsey JN, Faith EF, Logan SJ, Shenoy A, Schieffer KM, Cottrell CE, Lillis AP, Aldrink JH, Setty BA, Pearson GD. Syringocystadenocarcinoma Papilliferum in a Fifteen-Year-Old Girl: A Case Report and Review of the Literature. Case Rep Dermatol Med. 2022; 2022: 8076649.

                


                  Merjaneh N, Young J, Mangoli A, Olsen M, Setty B, Lane A, Nagarajan R, Pressey JG, Turpin B. Chemotherapy-induced thrombocytopenia in Ewing sarcoma: Implications and potential for romiplostim supportive care. Pediatr Blood Cancer. 2021 Dec 28;  e29548.

                


                  LaHaye S, Fitch JR, Voytovich KJ, Herman AC, Kelly BJ, Lammi GE, Arbesfeld JA, Wijeratne S, Franklin SJ, Schieffer KM, Bir N, McGrath SD, Miller AR, Wetzel A, Miller KE, Bedrosian TA, Leraas K, Varga EA, Lee K, Gupta A, Setty B, Boué DR, Leonard JR, Finlay JL, Abdelbaki MS, Osorio DS, Koo SC, Koboldt DC, Wagner AH, Eisfeld AK, Mrózek K, Magrini V, Cottrell CE, Mardis ER, Wilson RK, White P. Discovery of clinically relevant fusions in pediatric cancer. BMC Genomics. 2021 Dec 4; 22: 872.

                


                  Perisa MP, Stanek J, Setty BA, Nicol K, Yeager N. Evaluating Age-related Disparity of Outcomes in Ewing Sarcoma Patients Treated at a Pediatric Academic Medical Center. J Pediatr Hematol Oncol. 2021 Jul 1; 43: e702-e706.

                


                  Osman AF, Setty BA. Case 3: Abdominal Distention, Shock, and Neonatal Encephalopathy. Neoreviews. 2021 Jun; 22: e406-e408.

                


                  Orr A, Liu H, Mariani R, Aldrink JH, Setty BA, Koo S. Bilateral Lung Metastases From a Phalangeal Giant Cell Tumor of Bone. Pediatr Dev Pathol. 2021 Jan-Feb; 24: 51-55.

                


                  Gupta A, Belsky JA, Schieffer KM, Leraas K, Varga E, McGrath SD, Koo SC, Magrini V, Wilson RK, White P, Mardis ER, Jatana KR, Cottrell CE, Setty BA. Infantile fibrosarcoma-like tumor driven by novel RBPMS-MET fusion consolidated with cabozantinib. Cold Spring Harb Mol Case Stud. 2020 Oct; 6: 

                


                  Belsky JA, Wolf K, Setty BA. A Case of Resolved Vincristine-Induced Constipation Following Osteopathic Medicine in a Patient With Infantile Fibrosarcoma. J Am Osteopath Assoc. 2020 Oct 1; 120: 691-695.

                


                  Oesterheld JE, Reed DR, Setty BA, Isakoff MS, Thompson P, Yin H, Hayashi M, Loeb DM, Smith T, Makanji R, Fridley BL, Wagner LM. Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation. Pediatr Blood Cancer. 2020 Jul; 67: e28370.

                


                  Setty BA, Jinesh GG, Arnold M, Pettersson F, Cheng CH, Cen L, Yoder SJ, Teer JK, Flores ER, Reed DR, Brohl AS. The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss. PLoS Genet. 2020 Apr; 16: e1008642.

                


                  Charan M, Dravid P, Cam M, Setty B, Roberts RD, Houghton PJ, Cam H. Tumor secreted ANGPTL2 facilitates recruitment of neutrophils to the lung to promote lung pre-metastatic niche formation and targeting ANGPTL2 signaling affects metastatic disease. Oncotarget. 2020 Feb 4; 11: 510-522.

                


                  Tullius BP, Setty BA, Lee DA. Natural Killer Cell Immunotherapy for Osteosarcoma. Adv Exp Med Biol. 2020; 1257: 141-154.

                


                  Streby KA, Currier MA, Triplet M, Ott K, Dishman DJ, Vaughan MR, Ranalli MA, Setty B, Skeens MA, Whiteside S, Yeager ND, Haworth KB, Simpson K, Conner J, Cripe TP. First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial. Mol Ther. 2019 Nov 6; 27: 1930-1938.

                


                  Patel P, Roberts R, Cole J, Stalling M, Nicol K, Hor K, Bowman J, Setty B. A Rare Case of an Intracardiac Myoepithelial Carcinoma in an Infant. J Pediatr Hematol Oncol. 2019 May; 41: e206-e209.

                


                  Shah N, Scharschmidt T, Fung B, Conces M, Setty BA. Aneursymal Bone Cyst: An Uncommon Paraspinal Tumor in Children. J Pediatr Hematol Oncol. 2019 Mar; 41: e129-e131.

                


                  Trucco M, Barredo JC, Goldberg J, Leclerc GM, Hale GA, Gill J, Setty B, Smith T, Lush R, Lee JK, Reed DR. A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG-asparaginase, and doxorubicin. Pediatr Blood Cancer. 2018 Sep; 65: e27224.

                


                  Setty BA, Stanek JR, Mascarenhas L, Miller A, Bagatell R, Okcu F, Nicholls L, Lysecki D, Gupta AA. VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma. Pediatr Blood Cancer. 2018 Jan; 65: 

                


                  Jacobson AE, Shah N, Setty BA. Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. Pediatr Blood Cancer. 2017 Aug; 64: 

                


                  Setty BA, Pillay Smiley N, Pool CM, Jin Y, Liu Y, Nelin LD. Hypoxia-induced proliferation of HeLa cells depends on epidermal growth factor receptor-mediated arginase II induction. Physiol Rep. 2017 Mar; 5: 

                


                  Audino AN, Setty BA, Yeager ND. Rhabdomyosarcoma of the Breast in Adolescent and Young Adult (AYA) Women. J Pediatr Hematol Oncol. 2017 Jan; 39: 62-66.

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 01/28/2011

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2011

Residency

University of Illinois Medical Center at Chicago

Date Completed: 06/30/2008

Medical School

BLDEA’s Shri B M Patil Medical College

Date Completed: 08/30/2003

Clinical Interests

Complex Vascular Anomalies Ewing Sarcoma Lymphatic Malformations Non Rhabdomyosarcoma Soft Tissue Tumors Osteosarcoma Rhabdomyosarcoma Venous Malformations

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Bhuvana A. Setty

Contact Information

• Call us at:
• (614) 722-3550
• Fax us at:
• (614) 722-3369
• PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Bhuvana A. Setty

Biography

Bhuvana Setty, MD, is a Pediatric Hematologist/Oncologist at Nationwide Children’s Hospital. Her clinical interests include treating pediatric and young adult patients with bone and soft tissue sarcomas, and patients with vascular anomalies. She is the Director of the Clinical Sarcoma Team, an active member of the Hemangioma and Vascular Malformations Team, and the Lymphatic Imaging and Intervention Program. She is the Site Principal Investigator for The Sunshine Project, an early phase clinical trial consortium and CaNVAS, the Consortium of iNvestigators for Vascular Anomalies. Her research interests include developing translational and therapeutic clinical trials with novel agents for patients with aggressive bone and soft tissue sarcomas, and for patients with complex vascular anomalies.

Biography

Bhuvana Setty, MD, is a Pediatric Hematologist/Oncologist at Nationwide Children’s Hospital. Her clinical interests include treating pediatric and young adult patients with bone and soft tissue sarcomas, and patients with vascular anomalies. She is the Director of the Clinical Sarcoma Team, an active member of the Hemangioma and Vascular Malformations Team, and the Lymphatic Imaging and Intervention Program. She is the Site Principal Investigator for The Sunshine Project, an early phase clinical trial consortium and CaNVAS, the Consortium of iNvestigators for Vascular Anomalies. Her research interests include developing translational and therapeutic clinical trials with novel agents for patients with aggressive bone and soft tissue sarcomas, and for patients with complex vascular anomalies.

Biography

Bhuvana Setty, MD, is a Pediatric Hematologist/Oncologist at Nationwide Children’s Hospital. Her clinical interests include treating pediatric and young adult patients with bone and soft tissue sarcomas, and patients with vascular anomalies. She is the Director of the Clinical Sarcoma Team, an active member of the Hemangioma and Vascular Malformations Team, and the Lymphatic Imaging and Intervention Program. She is the Site Principal Investigator for The Sunshine Project, an early phase clinical trial consortium and CaNVAS, the Consortium of iNvestigators for Vascular Anomalies. Her research interests include developing translational and therapeutic clinical trials with novel agents for patients with aggressive bone and soft tissue sarcomas, and for patients with complex vascular anomalies.

Bhuvana Setty, MD, is a Pediatric Hematologist/Oncologist at Nationwide Children’s Hospital. Her clinical interests include treating pediatric and young adult patients with bone and soft tissue sarcomas, and patients with vascular anomalies. She is the Director of the Clinical Sarcoma Team, an active member of the Hemangioma and Vascular Malformations Team, and the Lymphatic Imaging and Intervention Program. She is the Site Principal Investigator for The Sunshine Project, an early phase clinical trial consortium and CaNVAS, the Consortium of iNvestigators for Vascular Anomalies. Her research interests include developing translational and therapeutic clinical trials with novel agents for patients with aggressive bone and soft tissue sarcomas, and for patients with complex vascular anomalies.

Bhuvana Setty, MD, is a Pediatric Hematologist/Oncologist at Nationwide Children’s Hospital. Her clinical interests include treating pediatric and young adult patients with bone and soft tissue sarcomas, and patients with vascular anomalies. She is the Director of the Clinical Sarcoma Team, an active member of the Hemangioma and Vascular Malformations Team, and the Lymphatic Imaging and Intervention Program. She is the Site Principal Investigator for The Sunshine Project, an early phase clinical trial consortium and CaNVAS, the Consortium of iNvestigators for Vascular Anomalies.

Her research interests include developing translational and therapeutic clinical trials with novel agents for patients with aggressive bone and soft tissue sarcomas, and for patients with complex vascular anomalies.

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Languages Spoken

English Hindi Kannada

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Languages Spoken

English Hindi Kannada

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Languages Spoken

English Hindi Kannada

Locations

Main Campus of Nationwide Children’s Hospital

Languages Spoken

English Hindi Kannada

Locations

Main Campus of Nationwide Children’s Hospital

Languages Spoken

English Hindi Kannada

Locations

Main Campus of Nationwide Children’s Hospital

Languages Spoken

English Hindi Kannada

• Main Campus of Nationwide Children’s Hospital

• English

• Hindi

• Kannada

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Hematology, Oncology and BMT Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Hematology, Oncology and BMT Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Hematology, Oncology and BMT Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Hematology/Oncology & BMT

Physician Team

Hematology, Oncology and BMT Fellowship

Faculty

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

• Hematology/Oncology & BMT
• Physician Team
• Hematology, Oncology and BMT Fellowship
• Faculty
• Primary Department
• Pediatrics
• Primary Section
• Hematology & Oncology

Awards, Honors & Organizations

Outstanding Clinical-Translational Investigator Award, Hematology/Oncology/BMT, Nationwide Children’s Hospital, 2020 Faculty Professionalism Award, Hematology/Oncology/BMT, Nationwide Children’s Hospital, 2019 Commendation for Capstone Project Proposal, Harvard Medical School, 2014 Member, American Society of Clinical Oncology, 2018 - Present Member, International Society for the Study of Vascular Anomalies, 2018 - Present Member, Connective Tissue Oncology Society, 2010 - Present Member, Children’s Oncology Group, 2009 - Present Member, American Society of Pediatric Hematology/Oncology, 2008 - Present

Awards, Honors & Organizations

Outstanding Clinical-Translational Investigator Award, Hematology/Oncology/BMT, Nationwide Children’s Hospital, 2020 Faculty Professionalism Award, Hematology/Oncology/BMT, Nationwide Children’s Hospital, 2019 Commendation for Capstone Project Proposal, Harvard Medical School, 2014 Member, American Society of Clinical Oncology, 2018 - Present Member, International Society for the Study of Vascular Anomalies, 2018 - Present Member, Connective Tissue Oncology Society, 2010 - Present Member, Children’s Oncology Group, 2009 - Present Member, American Society of Pediatric Hematology/Oncology, 2008 - Present

Awards, Honors & Organizations

Outstanding Clinical-Translational Investigator Award, Hematology/Oncology/BMT, Nationwide Children’s Hospital, 2020 Faculty Professionalism Award, Hematology/Oncology/BMT, Nationwide Children’s Hospital, 2019 Commendation for Capstone Project Proposal, Harvard Medical School, 2014 Member, American Society of Clinical Oncology, 2018 - Present Member, International Society for the Study of Vascular Anomalies, 2018 - Present Member, Connective Tissue Oncology Society, 2010 - Present Member, Children’s Oncology Group, 2009 - Present Member, American Society of Pediatric Hematology/Oncology, 2008 - Present

Outstanding Clinical-Translational Investigator Award, Hematology/Oncology/BMT, Nationwide Children’s Hospital, 2020 Faculty Professionalism Award, Hematology/Oncology/BMT, Nationwide Children’s Hospital, 2019 Commendation for Capstone Project Proposal, Harvard Medical School, 2014 Member, American Society of Clinical Oncology, 2018 - Present Member, International Society for the Study of Vascular Anomalies, 2018 - Present Member, Connective Tissue Oncology Society, 2010 - Present Member, Children’s Oncology Group, 2009 - Present Member, American Society of Pediatric Hematology/Oncology, 2008 - Present

• Outstanding Clinical-Translational Investigator Award, Hematology/Oncology/BMT, Nationwide Children’s Hospital, 2020
• Faculty Professionalism Award, Hematology/Oncology/BMT, Nationwide Children’s Hospital, 2019
• Commendation for Capstone Project Proposal, Harvard Medical School, 2014
• Member, American Society of Clinical Oncology, 2018 - Present
• Member, International Society for the Study of Vascular Anomalies, 2018 - Present
• Member, Connective Tissue Oncology Society, 2010 - Present
• Member, Children’s Oncology Group, 2009 - Present
• Member, American Society of Pediatric Hematology/Oncology, 2008 - Present

Research

Interests

Complex Vascular Malformations Ewing Sarcoma Osteosarcoma Rhabdomyosarcoma

Publications

                  Abdelbaki MS, DeWire Schottmiller MD, Cripe TP, Curry RC, Cruze CA, Her L, Demko S, Casey D, Setty B. An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumors. Heliyon. 2022 Dec; 8: e12450.

                


                  Hou YC, Evenson MJ, Corliss MM, Mahapatra L, Aldawood A, Carpentieri DF, Chamlin SL, Kulungowski AM, Madan-Khetarpal S, Sebastian J, Pet MA, Coughlin CC, Willing MC, Pearson GD, Setty BA, El-Haffaf Z, Cottrell CE, Parikh BA, Krysiak K, Schroeder MC, Heusel JW, Neidich JA, Cao Y. A Comparative Analysis of RAS Variants in Patients with Disorders of Somatic Mosaicism. Genet Med. 2022 Nov 29;  

                


                  Setty BA, Wusik K, Hammill AM. How we approach genetics in the diagnosis and management of vascular anomalies. Pediatr Blood Cancer. 2022 Aug; 69 Suppl 3: e29320.

                


                  Koo SC, Schieffer KM, Lee K, Gupta A, Pfau RB, Avenarius MR, Stonerock E, LaHaye S, Fitch J, Setty BA, Roberts R, Ranalli M, Conces MR, Bu F, Mardis ER, Cottrell CE. EGFR internal tandem duplications in fusion-negative congenital and neonatal spindle cell tumors. Genes Chromosomes Cancer. 2022 Jul 7;  

                


                  de Souza Fernandez Pereira M, Carr DR, Gatti-Mays ME, Olsen MR, Setty BA, Shahwan KT, Lee DA. Natural Killer Cell Recognition and Control of Epithelial Cancers. Cancer J. 2022 Jul-Aug 01; 28: 263-269.

                


                  Pearson AD, Gaspar N, Janeway K, Campbell-Hewson Q, Lawlor ER, Copland C, Karres D, Norga K, Benzaghou F, Weiner S, Weigel B, Weiss AR, Strauss SJ, Smith M, Setty BA, Seibel N, Scobie N, Pappo A, Okpara CE, Nysom K, McDonough J, Marshall LV, Ludwinski D, Ligas F, Lesa G, Knudsen S, Kauh J, Hsieh A, Heenen D, Hawkins DS, Graham A, Garmey E, DuBois SG, Fox E, Donoghue M, de Rojas T, Chung J, Casanova M, Brennan B, Bishop M, Buenger V, Reaman G, Vassal G. Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. Eur J Cancer. 2022 Jul 18; 173: 71-90.

                


                  Fetzko S, Fonseca A, Frances Wedekind M, Gupta AA, Setty BA, Schraw J, Lupo PJ, Guillerman RP, Butala AA, Russell H, Nicholls L, Walterhouse D, Hawkins DS, Okcu MF. Is Detection of Relapse by Surveillance Imaging Associated With Longer Survival in Patients With Rhabdomyosarcoma? J Pediatr Hematol Oncol. 2022 Feb 9;  

                


                  Baliga S, Matsui J, Klamer B, Cetnar A, Ewing A, Cadieux C, Gupta A, Setty BA, Roberts RD, Olshefski RS, Cripe TP, Scharschmidt TJ, Aldrink J, Mardis E, Yeager ND, Palmer JD. Clinical outcomes and efficacy of stereotactic body radiation therapy in children, adolescents, and young adults with metastatic solid tumors. Br J Radiol. 2022 Feb 10;  20211088.

                


                  Halsey JN, Faith EF, Logan SJ, Shenoy A, Schieffer KM, Cottrell CE, Lillis AP, Aldrink JH, Setty BA, Pearson GD. Syringocystadenocarcinoma Papilliferum in a Fifteen-Year-Old Girl: A Case Report and Review of the Literature. Case Rep Dermatol Med. 2022; 2022: 8076649.

                


                  Merjaneh N, Young J, Mangoli A, Olsen M, Setty B, Lane A, Nagarajan R, Pressey JG, Turpin B. Chemotherapy-induced thrombocytopenia in Ewing sarcoma: Implications and potential for romiplostim supportive care. Pediatr Blood Cancer. 2021 Dec 28;  e29548.

                


                  LaHaye S, Fitch JR, Voytovich KJ, Herman AC, Kelly BJ, Lammi GE, Arbesfeld JA, Wijeratne S, Franklin SJ, Schieffer KM, Bir N, McGrath SD, Miller AR, Wetzel A, Miller KE, Bedrosian TA, Leraas K, Varga EA, Lee K, Gupta A, Setty B, Boué DR, Leonard JR, Finlay JL, Abdelbaki MS, Osorio DS, Koo SC, Koboldt DC, Wagner AH, Eisfeld AK, Mrózek K, Magrini V, Cottrell CE, Mardis ER, Wilson RK, White P. Discovery of clinically relevant fusions in pediatric cancer. BMC Genomics. 2021 Dec 4; 22: 872.

                


                  Perisa MP, Stanek J, Setty BA, Nicol K, Yeager N. Evaluating Age-related Disparity of Outcomes in Ewing Sarcoma Patients Treated at a Pediatric Academic Medical Center. J Pediatr Hematol Oncol. 2021 Jul 1; 43: e702-e706.

                


                  Osman AF, Setty BA. Case 3: Abdominal Distention, Shock, and Neonatal Encephalopathy. Neoreviews. 2021 Jun; 22: e406-e408.

                


                  Orr A, Liu H, Mariani R, Aldrink JH, Setty BA, Koo S. Bilateral Lung Metastases From a Phalangeal Giant Cell Tumor of Bone. Pediatr Dev Pathol. 2021 Jan-Feb; 24: 51-55.

                


                  Gupta A, Belsky JA, Schieffer KM, Leraas K, Varga E, McGrath SD, Koo SC, Magrini V, Wilson RK, White P, Mardis ER, Jatana KR, Cottrell CE, Setty BA. Infantile fibrosarcoma-like tumor driven by novel RBPMS-MET fusion consolidated with cabozantinib. Cold Spring Harb Mol Case Stud. 2020 Oct; 6: 

                


                  Belsky JA, Wolf K, Setty BA. A Case of Resolved Vincristine-Induced Constipation Following Osteopathic Medicine in a Patient With Infantile Fibrosarcoma. J Am Osteopath Assoc. 2020 Oct 1; 120: 691-695.

                


                  Oesterheld JE, Reed DR, Setty BA, Isakoff MS, Thompson P, Yin H, Hayashi M, Loeb DM, Smith T, Makanji R, Fridley BL, Wagner LM. Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation. Pediatr Blood Cancer. 2020 Jul; 67: e28370.

                


                  Setty BA, Jinesh GG, Arnold M, Pettersson F, Cheng CH, Cen L, Yoder SJ, Teer JK, Flores ER, Reed DR, Brohl AS. The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss. PLoS Genet. 2020 Apr; 16: e1008642.

                


                  Charan M, Dravid P, Cam M, Setty B, Roberts RD, Houghton PJ, Cam H. Tumor secreted ANGPTL2 facilitates recruitment of neutrophils to the lung to promote lung pre-metastatic niche formation and targeting ANGPTL2 signaling affects metastatic disease. Oncotarget. 2020 Feb 4; 11: 510-522.

                


                  Tullius BP, Setty BA, Lee DA. Natural Killer Cell Immunotherapy for Osteosarcoma. Adv Exp Med Biol. 2020; 1257: 141-154.

                


                  Streby KA, Currier MA, Triplet M, Ott K, Dishman DJ, Vaughan MR, Ranalli MA, Setty B, Skeens MA, Whiteside S, Yeager ND, Haworth KB, Simpson K, Conner J, Cripe TP. First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial. Mol Ther. 2019 Nov 6; 27: 1930-1938.

                


                  Patel P, Roberts R, Cole J, Stalling M, Nicol K, Hor K, Bowman J, Setty B. A Rare Case of an Intracardiac Myoepithelial Carcinoma in an Infant. J Pediatr Hematol Oncol. 2019 May; 41: e206-e209.

                


                  Shah N, Scharschmidt T, Fung B, Conces M, Setty BA. Aneursymal Bone Cyst: An Uncommon Paraspinal Tumor in Children. J Pediatr Hematol Oncol. 2019 Mar; 41: e129-e131.

                


                  Trucco M, Barredo JC, Goldberg J, Leclerc GM, Hale GA, Gill J, Setty B, Smith T, Lush R, Lee JK, Reed DR. A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG-asparaginase, and doxorubicin. Pediatr Blood Cancer. 2018 Sep; 65: e27224.

                


                  Setty BA, Stanek JR, Mascarenhas L, Miller A, Bagatell R, Okcu F, Nicholls L, Lysecki D, Gupta AA. VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma. Pediatr Blood Cancer. 2018 Jan; 65: 

                


                  Jacobson AE, Shah N, Setty BA. Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. Pediatr Blood Cancer. 2017 Aug; 64: 

                


                  Setty BA, Pillay Smiley N, Pool CM, Jin Y, Liu Y, Nelin LD. Hypoxia-induced proliferation of HeLa cells depends on epidermal growth factor receptor-mediated arginase II induction. Physiol Rep. 2017 Mar; 5: 

                


                  Audino AN, Setty BA, Yeager ND. Rhabdomyosarcoma of the Breast in Adolescent and Young Adult (AYA) Women. J Pediatr Hematol Oncol. 2017 Jan; 39: 62-66.

View More Publications

Research

Interests

Complex Vascular Malformations Ewing Sarcoma Osteosarcoma Rhabdomyosarcoma

Publications

                  Abdelbaki MS, DeWire Schottmiller MD, Cripe TP, Curry RC, Cruze CA, Her L, Demko S, Casey D, Setty B. An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumors. Heliyon. 2022 Dec; 8: e12450.

                


                  Hou YC, Evenson MJ, Corliss MM, Mahapatra L, Aldawood A, Carpentieri DF, Chamlin SL, Kulungowski AM, Madan-Khetarpal S, Sebastian J, Pet MA, Coughlin CC, Willing MC, Pearson GD, Setty BA, El-Haffaf Z, Cottrell CE, Parikh BA, Krysiak K, Schroeder MC, Heusel JW, Neidich JA, Cao Y. A Comparative Analysis of RAS Variants in Patients with Disorders of Somatic Mosaicism. Genet Med. 2022 Nov 29;  

                


                  Setty BA, Wusik K, Hammill AM. How we approach genetics in the diagnosis and management of vascular anomalies. Pediatr Blood Cancer. 2022 Aug; 69 Suppl 3: e29320.

                


                  Koo SC, Schieffer KM, Lee K, Gupta A, Pfau RB, Avenarius MR, Stonerock E, LaHaye S, Fitch J, Setty BA, Roberts R, Ranalli M, Conces MR, Bu F, Mardis ER, Cottrell CE. EGFR internal tandem duplications in fusion-negative congenital and neonatal spindle cell tumors. Genes Chromosomes Cancer. 2022 Jul 7;  

                


                  de Souza Fernandez Pereira M, Carr DR, Gatti-Mays ME, Olsen MR, Setty BA, Shahwan KT, Lee DA. Natural Killer Cell Recognition and Control of Epithelial Cancers. Cancer J. 2022 Jul-Aug 01; 28: 263-269.

                


                  Pearson AD, Gaspar N, Janeway K, Campbell-Hewson Q, Lawlor ER, Copland C, Karres D, Norga K, Benzaghou F, Weiner S, Weigel B, Weiss AR, Strauss SJ, Smith M, Setty BA, Seibel N, Scobie N, Pappo A, Okpara CE, Nysom K, McDonough J, Marshall LV, Ludwinski D, Ligas F, Lesa G, Knudsen S, Kauh J, Hsieh A, Heenen D, Hawkins DS, Graham A, Garmey E, DuBois SG, Fox E, Donoghue M, de Rojas T, Chung J, Casanova M, Brennan B, Bishop M, Buenger V, Reaman G, Vassal G. Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. Eur J Cancer. 2022 Jul 18; 173: 71-90.

                


                  Fetzko S, Fonseca A, Frances Wedekind M, Gupta AA, Setty BA, Schraw J, Lupo PJ, Guillerman RP, Butala AA, Russell H, Nicholls L, Walterhouse D, Hawkins DS, Okcu MF. Is Detection of Relapse by Surveillance Imaging Associated With Longer Survival in Patients With Rhabdomyosarcoma? J Pediatr Hematol Oncol. 2022 Feb 9;  

                


                  Baliga S, Matsui J, Klamer B, Cetnar A, Ewing A, Cadieux C, Gupta A, Setty BA, Roberts RD, Olshefski RS, Cripe TP, Scharschmidt TJ, Aldrink J, Mardis E, Yeager ND, Palmer JD. Clinical outcomes and efficacy of stereotactic body radiation therapy in children, adolescents, and young adults with metastatic solid tumors. Br J Radiol. 2022 Feb 10;  20211088.

                


                  Halsey JN, Faith EF, Logan SJ, Shenoy A, Schieffer KM, Cottrell CE, Lillis AP, Aldrink JH, Setty BA, Pearson GD. Syringocystadenocarcinoma Papilliferum in a Fifteen-Year-Old Girl: A Case Report and Review of the Literature. Case Rep Dermatol Med. 2022; 2022: 8076649.

                


                  Merjaneh N, Young J, Mangoli A, Olsen M, Setty B, Lane A, Nagarajan R, Pressey JG, Turpin B. Chemotherapy-induced thrombocytopenia in Ewing sarcoma: Implications and potential for romiplostim supportive care. Pediatr Blood Cancer. 2021 Dec 28;  e29548.

                


                  LaHaye S, Fitch JR, Voytovich KJ, Herman AC, Kelly BJ, Lammi GE, Arbesfeld JA, Wijeratne S, Franklin SJ, Schieffer KM, Bir N, McGrath SD, Miller AR, Wetzel A, Miller KE, Bedrosian TA, Leraas K, Varga EA, Lee K, Gupta A, Setty B, Boué DR, Leonard JR, Finlay JL, Abdelbaki MS, Osorio DS, Koo SC, Koboldt DC, Wagner AH, Eisfeld AK, Mrózek K, Magrini V, Cottrell CE, Mardis ER, Wilson RK, White P. Discovery of clinically relevant fusions in pediatric cancer. BMC Genomics. 2021 Dec 4; 22: 872.

                


                  Perisa MP, Stanek J, Setty BA, Nicol K, Yeager N. Evaluating Age-related Disparity of Outcomes in Ewing Sarcoma Patients Treated at a Pediatric Academic Medical Center. J Pediatr Hematol Oncol. 2021 Jul 1; 43: e702-e706.

                


                  Osman AF, Setty BA. Case 3: Abdominal Distention, Shock, and Neonatal Encephalopathy. Neoreviews. 2021 Jun; 22: e406-e408.

                


                  Orr A, Liu H, Mariani R, Aldrink JH, Setty BA, Koo S. Bilateral Lung Metastases From a Phalangeal Giant Cell Tumor of Bone. Pediatr Dev Pathol. 2021 Jan-Feb; 24: 51-55.

                


                  Gupta A, Belsky JA, Schieffer KM, Leraas K, Varga E, McGrath SD, Koo SC, Magrini V, Wilson RK, White P, Mardis ER, Jatana KR, Cottrell CE, Setty BA. Infantile fibrosarcoma-like tumor driven by novel RBPMS-MET fusion consolidated with cabozantinib. Cold Spring Harb Mol Case Stud. 2020 Oct; 6: 

                


                  Belsky JA, Wolf K, Setty BA. A Case of Resolved Vincristine-Induced Constipation Following Osteopathic Medicine in a Patient With Infantile Fibrosarcoma. J Am Osteopath Assoc. 2020 Oct 1; 120: 691-695.

                


                  Oesterheld JE, Reed DR, Setty BA, Isakoff MS, Thompson P, Yin H, Hayashi M, Loeb DM, Smith T, Makanji R, Fridley BL, Wagner LM. Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation. Pediatr Blood Cancer. 2020 Jul; 67: e28370.

                


                  Setty BA, Jinesh GG, Arnold M, Pettersson F, Cheng CH, Cen L, Yoder SJ, Teer JK, Flores ER, Reed DR, Brohl AS. The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss. PLoS Genet. 2020 Apr; 16: e1008642.

                


                  Charan M, Dravid P, Cam M, Setty B, Roberts RD, Houghton PJ, Cam H. Tumor secreted ANGPTL2 facilitates recruitment of neutrophils to the lung to promote lung pre-metastatic niche formation and targeting ANGPTL2 signaling affects metastatic disease. Oncotarget. 2020 Feb 4; 11: 510-522.

                


                  Tullius BP, Setty BA, Lee DA. Natural Killer Cell Immunotherapy for Osteosarcoma. Adv Exp Med Biol. 2020; 1257: 141-154.

                


                  Streby KA, Currier MA, Triplet M, Ott K, Dishman DJ, Vaughan MR, Ranalli MA, Setty B, Skeens MA, Whiteside S, Yeager ND, Haworth KB, Simpson K, Conner J, Cripe TP. First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial. Mol Ther. 2019 Nov 6; 27: 1930-1938.

                


                  Patel P, Roberts R, Cole J, Stalling M, Nicol K, Hor K, Bowman J, Setty B. A Rare Case of an Intracardiac Myoepithelial Carcinoma in an Infant. J Pediatr Hematol Oncol. 2019 May; 41: e206-e209.

                


                  Shah N, Scharschmidt T, Fung B, Conces M, Setty BA. Aneursymal Bone Cyst: An Uncommon Paraspinal Tumor in Children. J Pediatr Hematol Oncol. 2019 Mar; 41: e129-e131.

                


                  Trucco M, Barredo JC, Goldberg J, Leclerc GM, Hale GA, Gill J, Setty B, Smith T, Lush R, Lee JK, Reed DR. A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG-asparaginase, and doxorubicin. Pediatr Blood Cancer. 2018 Sep; 65: e27224.

                


                  Setty BA, Stanek JR, Mascarenhas L, Miller A, Bagatell R, Okcu F, Nicholls L, Lysecki D, Gupta AA. VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma. Pediatr Blood Cancer. 2018 Jan; 65: 

                


                  Jacobson AE, Shah N, Setty BA. Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. Pediatr Blood Cancer. 2017 Aug; 64: 

                


                  Setty BA, Pillay Smiley N, Pool CM, Jin Y, Liu Y, Nelin LD. Hypoxia-induced proliferation of HeLa cells depends on epidermal growth factor receptor-mediated arginase II induction. Physiol Rep. 2017 Mar; 5: 

                


                  Audino AN, Setty BA, Yeager ND. Rhabdomyosarcoma of the Breast in Adolescent and Young Adult (AYA) Women. J Pediatr Hematol Oncol. 2017 Jan; 39: 62-66.

View More Publications

Research

Interests

Complex Vascular Malformations Ewing Sarcoma Osteosarcoma Rhabdomyosarcoma

Publications

                  Abdelbaki MS, DeWire Schottmiller MD, Cripe TP, Curry RC, Cruze CA, Her L, Demko S, Casey D, Setty B. An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumors. Heliyon. 2022 Dec; 8: e12450.

                


                  Hou YC, Evenson MJ, Corliss MM, Mahapatra L, Aldawood A, Carpentieri DF, Chamlin SL, Kulungowski AM, Madan-Khetarpal S, Sebastian J, Pet MA, Coughlin CC, Willing MC, Pearson GD, Setty BA, El-Haffaf Z, Cottrell CE, Parikh BA, Krysiak K, Schroeder MC, Heusel JW, Neidich JA, Cao Y. A Comparative Analysis of RAS Variants in Patients with Disorders of Somatic Mosaicism. Genet Med. 2022 Nov 29;  

                


                  Setty BA, Wusik K, Hammill AM. How we approach genetics in the diagnosis and management of vascular anomalies. Pediatr Blood Cancer. 2022 Aug; 69 Suppl 3: e29320.

                


                  Koo SC, Schieffer KM, Lee K, Gupta A, Pfau RB, Avenarius MR, Stonerock E, LaHaye S, Fitch J, Setty BA, Roberts R, Ranalli M, Conces MR, Bu F, Mardis ER, Cottrell CE. EGFR internal tandem duplications in fusion-negative congenital and neonatal spindle cell tumors. Genes Chromosomes Cancer. 2022 Jul 7;  

                


                  de Souza Fernandez Pereira M, Carr DR, Gatti-Mays ME, Olsen MR, Setty BA, Shahwan KT, Lee DA. Natural Killer Cell Recognition and Control of Epithelial Cancers. Cancer J. 2022 Jul-Aug 01; 28: 263-269.

                


                  Pearson AD, Gaspar N, Janeway K, Campbell-Hewson Q, Lawlor ER, Copland C, Karres D, Norga K, Benzaghou F, Weiner S, Weigel B, Weiss AR, Strauss SJ, Smith M, Setty BA, Seibel N, Scobie N, Pappo A, Okpara CE, Nysom K, McDonough J, Marshall LV, Ludwinski D, Ligas F, Lesa G, Knudsen S, Kauh J, Hsieh A, Heenen D, Hawkins DS, Graham A, Garmey E, DuBois SG, Fox E, Donoghue M, de Rojas T, Chung J, Casanova M, Brennan B, Bishop M, Buenger V, Reaman G, Vassal G. Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. Eur J Cancer. 2022 Jul 18; 173: 71-90.

                


                  Fetzko S, Fonseca A, Frances Wedekind M, Gupta AA, Setty BA, Schraw J, Lupo PJ, Guillerman RP, Butala AA, Russell H, Nicholls L, Walterhouse D, Hawkins DS, Okcu MF. Is Detection of Relapse by Surveillance Imaging Associated With Longer Survival in Patients With Rhabdomyosarcoma? J Pediatr Hematol Oncol. 2022 Feb 9;  

                


                  Baliga S, Matsui J, Klamer B, Cetnar A, Ewing A, Cadieux C, Gupta A, Setty BA, Roberts RD, Olshefski RS, Cripe TP, Scharschmidt TJ, Aldrink J, Mardis E, Yeager ND, Palmer JD. Clinical outcomes and efficacy of stereotactic body radiation therapy in children, adolescents, and young adults with metastatic solid tumors. Br J Radiol. 2022 Feb 10;  20211088.

                


                  Halsey JN, Faith EF, Logan SJ, Shenoy A, Schieffer KM, Cottrell CE, Lillis AP, Aldrink JH, Setty BA, Pearson GD. Syringocystadenocarcinoma Papilliferum in a Fifteen-Year-Old Girl: A Case Report and Review of the Literature. Case Rep Dermatol Med. 2022; 2022: 8076649.

                


                  Merjaneh N, Young J, Mangoli A, Olsen M, Setty B, Lane A, Nagarajan R, Pressey JG, Turpin B. Chemotherapy-induced thrombocytopenia in Ewing sarcoma: Implications and potential for romiplostim supportive care. Pediatr Blood Cancer. 2021 Dec 28;  e29548.

                


                  LaHaye S, Fitch JR, Voytovich KJ, Herman AC, Kelly BJ, Lammi GE, Arbesfeld JA, Wijeratne S, Franklin SJ, Schieffer KM, Bir N, McGrath SD, Miller AR, Wetzel A, Miller KE, Bedrosian TA, Leraas K, Varga EA, Lee K, Gupta A, Setty B, Boué DR, Leonard JR, Finlay JL, Abdelbaki MS, Osorio DS, Koo SC, Koboldt DC, Wagner AH, Eisfeld AK, Mrózek K, Magrini V, Cottrell CE, Mardis ER, Wilson RK, White P. Discovery of clinically relevant fusions in pediatric cancer. BMC Genomics. 2021 Dec 4; 22: 872.

                


                  Perisa MP, Stanek J, Setty BA, Nicol K, Yeager N. Evaluating Age-related Disparity of Outcomes in Ewing Sarcoma Patients Treated at a Pediatric Academic Medical Center. J Pediatr Hematol Oncol. 2021 Jul 1; 43: e702-e706.

                


                  Osman AF, Setty BA. Case 3: Abdominal Distention, Shock, and Neonatal Encephalopathy. Neoreviews. 2021 Jun; 22: e406-e408.

                


                  Orr A, Liu H, Mariani R, Aldrink JH, Setty BA, Koo S. Bilateral Lung Metastases From a Phalangeal Giant Cell Tumor of Bone. Pediatr Dev Pathol. 2021 Jan-Feb; 24: 51-55.

                


                  Gupta A, Belsky JA, Schieffer KM, Leraas K, Varga E, McGrath SD, Koo SC, Magrini V, Wilson RK, White P, Mardis ER, Jatana KR, Cottrell CE, Setty BA. Infantile fibrosarcoma-like tumor driven by novel RBPMS-MET fusion consolidated with cabozantinib. Cold Spring Harb Mol Case Stud. 2020 Oct; 6: 

                


                  Belsky JA, Wolf K, Setty BA. A Case of Resolved Vincristine-Induced Constipation Following Osteopathic Medicine in a Patient With Infantile Fibrosarcoma. J Am Osteopath Assoc. 2020 Oct 1; 120: 691-695.

                


                  Oesterheld JE, Reed DR, Setty BA, Isakoff MS, Thompson P, Yin H, Hayashi M, Loeb DM, Smith T, Makanji R, Fridley BL, Wagner LM. Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation. Pediatr Blood Cancer. 2020 Jul; 67: e28370.

                


                  Setty BA, Jinesh GG, Arnold M, Pettersson F, Cheng CH, Cen L, Yoder SJ, Teer JK, Flores ER, Reed DR, Brohl AS. The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss. PLoS Genet. 2020 Apr; 16: e1008642.

                


                  Charan M, Dravid P, Cam M, Setty B, Roberts RD, Houghton PJ, Cam H. Tumor secreted ANGPTL2 facilitates recruitment of neutrophils to the lung to promote lung pre-metastatic niche formation and targeting ANGPTL2 signaling affects metastatic disease. Oncotarget. 2020 Feb 4; 11: 510-522.

                


                  Tullius BP, Setty BA, Lee DA. Natural Killer Cell Immunotherapy for Osteosarcoma. Adv Exp Med Biol. 2020; 1257: 141-154.

                


                  Streby KA, Currier MA, Triplet M, Ott K, Dishman DJ, Vaughan MR, Ranalli MA, Setty B, Skeens MA, Whiteside S, Yeager ND, Haworth KB, Simpson K, Conner J, Cripe TP. First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial. Mol Ther. 2019 Nov 6; 27: 1930-1938.

                


                  Patel P, Roberts R, Cole J, Stalling M, Nicol K, Hor K, Bowman J, Setty B. A Rare Case of an Intracardiac Myoepithelial Carcinoma in an Infant. J Pediatr Hematol Oncol. 2019 May; 41: e206-e209.

                


                  Shah N, Scharschmidt T, Fung B, Conces M, Setty BA. Aneursymal Bone Cyst: An Uncommon Paraspinal Tumor in Children. J Pediatr Hematol Oncol. 2019 Mar; 41: e129-e131.

                


                  Trucco M, Barredo JC, Goldberg J, Leclerc GM, Hale GA, Gill J, Setty B, Smith T, Lush R, Lee JK, Reed DR. A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG-asparaginase, and doxorubicin. Pediatr Blood Cancer. 2018 Sep; 65: e27224.

                


                  Setty BA, Stanek JR, Mascarenhas L, Miller A, Bagatell R, Okcu F, Nicholls L, Lysecki D, Gupta AA. VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma. Pediatr Blood Cancer. 2018 Jan; 65: 

                


                  Jacobson AE, Shah N, Setty BA. Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. Pediatr Blood Cancer. 2017 Aug; 64: 

                


                  Setty BA, Pillay Smiley N, Pool CM, Jin Y, Liu Y, Nelin LD. Hypoxia-induced proliferation of HeLa cells depends on epidermal growth factor receptor-mediated arginase II induction. Physiol Rep. 2017 Mar; 5: 

                


                  Audino AN, Setty BA, Yeager ND. Rhabdomyosarcoma of the Breast in Adolescent and Young Adult (AYA) Women. J Pediatr Hematol Oncol. 2017 Jan; 39: 62-66.

View More Publications

Interests

Complex Vascular Malformations Ewing Sarcoma Osteosarcoma Rhabdomyosarcoma

Publications

                  Abdelbaki MS, DeWire Schottmiller MD, Cripe TP, Curry RC, Cruze CA, Her L, Demko S, Casey D, Setty B. An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumors. Heliyon. 2022 Dec; 8: e12450.

                


                  Hou YC, Evenson MJ, Corliss MM, Mahapatra L, Aldawood A, Carpentieri DF, Chamlin SL, Kulungowski AM, Madan-Khetarpal S, Sebastian J, Pet MA, Coughlin CC, Willing MC, Pearson GD, Setty BA, El-Haffaf Z, Cottrell CE, Parikh BA, Krysiak K, Schroeder MC, Heusel JW, Neidich JA, Cao Y. A Comparative Analysis of RAS Variants in Patients with Disorders of Somatic Mosaicism. Genet Med. 2022 Nov 29;  

                


                  Setty BA, Wusik K, Hammill AM. How we approach genetics in the diagnosis and management of vascular anomalies. Pediatr Blood Cancer. 2022 Aug; 69 Suppl 3: e29320.

                


                  Koo SC, Schieffer KM, Lee K, Gupta A, Pfau RB, Avenarius MR, Stonerock E, LaHaye S, Fitch J, Setty BA, Roberts R, Ranalli M, Conces MR, Bu F, Mardis ER, Cottrell CE. EGFR internal tandem duplications in fusion-negative congenital and neonatal spindle cell tumors. Genes Chromosomes Cancer. 2022 Jul 7;  

                


                  de Souza Fernandez Pereira M, Carr DR, Gatti-Mays ME, Olsen MR, Setty BA, Shahwan KT, Lee DA. Natural Killer Cell Recognition and Control of Epithelial Cancers. Cancer J. 2022 Jul-Aug 01; 28: 263-269.

                


                  Pearson AD, Gaspar N, Janeway K, Campbell-Hewson Q, Lawlor ER, Copland C, Karres D, Norga K, Benzaghou F, Weiner S, Weigel B, Weiss AR, Strauss SJ, Smith M, Setty BA, Seibel N, Scobie N, Pappo A, Okpara CE, Nysom K, McDonough J, Marshall LV, Ludwinski D, Ligas F, Lesa G, Knudsen S, Kauh J, Hsieh A, Heenen D, Hawkins DS, Graham A, Garmey E, DuBois SG, Fox E, Donoghue M, de Rojas T, Chung J, Casanova M, Brennan B, Bishop M, Buenger V, Reaman G, Vassal G. Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. Eur J Cancer. 2022 Jul 18; 173: 71-90.

                


                  Fetzko S, Fonseca A, Frances Wedekind M, Gupta AA, Setty BA, Schraw J, Lupo PJ, Guillerman RP, Butala AA, Russell H, Nicholls L, Walterhouse D, Hawkins DS, Okcu MF. Is Detection of Relapse by Surveillance Imaging Associated With Longer Survival in Patients With Rhabdomyosarcoma? J Pediatr Hematol Oncol. 2022 Feb 9;  

                


                  Baliga S, Matsui J, Klamer B, Cetnar A, Ewing A, Cadieux C, Gupta A, Setty BA, Roberts RD, Olshefski RS, Cripe TP, Scharschmidt TJ, Aldrink J, Mardis E, Yeager ND, Palmer JD. Clinical outcomes and efficacy of stereotactic body radiation therapy in children, adolescents, and young adults with metastatic solid tumors. Br J Radiol. 2022 Feb 10;  20211088.

                


                  Halsey JN, Faith EF, Logan SJ, Shenoy A, Schieffer KM, Cottrell CE, Lillis AP, Aldrink JH, Setty BA, Pearson GD. Syringocystadenocarcinoma Papilliferum in a Fifteen-Year-Old Girl: A Case Report and Review of the Literature. Case Rep Dermatol Med. 2022; 2022: 8076649.

                


                  Merjaneh N, Young J, Mangoli A, Olsen M, Setty B, Lane A, Nagarajan R, Pressey JG, Turpin B. Chemotherapy-induced thrombocytopenia in Ewing sarcoma: Implications and potential for romiplostim supportive care. Pediatr Blood Cancer. 2021 Dec 28;  e29548.

                


                  LaHaye S, Fitch JR, Voytovich KJ, Herman AC, Kelly BJ, Lammi GE, Arbesfeld JA, Wijeratne S, Franklin SJ, Schieffer KM, Bir N, McGrath SD, Miller AR, Wetzel A, Miller KE, Bedrosian TA, Leraas K, Varga EA, Lee K, Gupta A, Setty B, Boué DR, Leonard JR, Finlay JL, Abdelbaki MS, Osorio DS, Koo SC, Koboldt DC, Wagner AH, Eisfeld AK, Mrózek K, Magrini V, Cottrell CE, Mardis ER, Wilson RK, White P. Discovery of clinically relevant fusions in pediatric cancer. BMC Genomics. 2021 Dec 4; 22: 872.

                


                  Perisa MP, Stanek J, Setty BA, Nicol K, Yeager N. Evaluating Age-related Disparity of Outcomes in Ewing Sarcoma Patients Treated at a Pediatric Academic Medical Center. J Pediatr Hematol Oncol. 2021 Jul 1; 43: e702-e706.

                


                  Osman AF, Setty BA. Case 3: Abdominal Distention, Shock, and Neonatal Encephalopathy. Neoreviews. 2021 Jun; 22: e406-e408.

                


                  Orr A, Liu H, Mariani R, Aldrink JH, Setty BA, Koo S. Bilateral Lung Metastases From a Phalangeal Giant Cell Tumor of Bone. Pediatr Dev Pathol. 2021 Jan-Feb; 24: 51-55.

                


                  Gupta A, Belsky JA, Schieffer KM, Leraas K, Varga E, McGrath SD, Koo SC, Magrini V, Wilson RK, White P, Mardis ER, Jatana KR, Cottrell CE, Setty BA. Infantile fibrosarcoma-like tumor driven by novel RBPMS-MET fusion consolidated with cabozantinib. Cold Spring Harb Mol Case Stud. 2020 Oct; 6: 

                


                  Belsky JA, Wolf K, Setty BA. A Case of Resolved Vincristine-Induced Constipation Following Osteopathic Medicine in a Patient With Infantile Fibrosarcoma. J Am Osteopath Assoc. 2020 Oct 1; 120: 691-695.

                


                  Oesterheld JE, Reed DR, Setty BA, Isakoff MS, Thompson P, Yin H, Hayashi M, Loeb DM, Smith T, Makanji R, Fridley BL, Wagner LM. Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation. Pediatr Blood Cancer. 2020 Jul; 67: e28370.

                


                  Setty BA, Jinesh GG, Arnold M, Pettersson F, Cheng CH, Cen L, Yoder SJ, Teer JK, Flores ER, Reed DR, Brohl AS. The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss. PLoS Genet. 2020 Apr; 16: e1008642.

                


                  Charan M, Dravid P, Cam M, Setty B, Roberts RD, Houghton PJ, Cam H. Tumor secreted ANGPTL2 facilitates recruitment of neutrophils to the lung to promote lung pre-metastatic niche formation and targeting ANGPTL2 signaling affects metastatic disease. Oncotarget. 2020 Feb 4; 11: 510-522.

                


                  Tullius BP, Setty BA, Lee DA. Natural Killer Cell Immunotherapy for Osteosarcoma. Adv Exp Med Biol. 2020; 1257: 141-154.

                


                  Streby KA, Currier MA, Triplet M, Ott K, Dishman DJ, Vaughan MR, Ranalli MA, Setty B, Skeens MA, Whiteside S, Yeager ND, Haworth KB, Simpson K, Conner J, Cripe TP. First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial. Mol Ther. 2019 Nov 6; 27: 1930-1938.

                


                  Patel P, Roberts R, Cole J, Stalling M, Nicol K, Hor K, Bowman J, Setty B. A Rare Case of an Intracardiac Myoepithelial Carcinoma in an Infant. J Pediatr Hematol Oncol. 2019 May; 41: e206-e209.

                


                  Shah N, Scharschmidt T, Fung B, Conces M, Setty BA. Aneursymal Bone Cyst: An Uncommon Paraspinal Tumor in Children. J Pediatr Hematol Oncol. 2019 Mar; 41: e129-e131.

                


                  Trucco M, Barredo JC, Goldberg J, Leclerc GM, Hale GA, Gill J, Setty B, Smith T, Lush R, Lee JK, Reed DR. A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG-asparaginase, and doxorubicin. Pediatr Blood Cancer. 2018 Sep; 65: e27224.

                


                  Setty BA, Stanek JR, Mascarenhas L, Miller A, Bagatell R, Okcu F, Nicholls L, Lysecki D, Gupta AA. VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma. Pediatr Blood Cancer. 2018 Jan; 65: 

                


                  Jacobson AE, Shah N, Setty BA. Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. Pediatr Blood Cancer. 2017 Aug; 64: 

                


                  Setty BA, Pillay Smiley N, Pool CM, Jin Y, Liu Y, Nelin LD. Hypoxia-induced proliferation of HeLa cells depends on epidermal growth factor receptor-mediated arginase II induction. Physiol Rep. 2017 Mar; 5: 

                


                  Audino AN, Setty BA, Yeager ND. Rhabdomyosarcoma of the Breast in Adolescent and Young Adult (AYA) Women. J Pediatr Hematol Oncol. 2017 Jan; 39: 62-66.

View More Publications

Interests

Complex Vascular Malformations Ewing Sarcoma Osteosarcoma Rhabdomyosarcoma

                  Abdelbaki MS, DeWire Schottmiller MD, Cripe TP, Curry RC, Cruze CA, Her L, Demko S, Casey D, Setty B. An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumors. Heliyon. 2022 Dec; 8: e12450.

                


                  Hou YC, Evenson MJ, Corliss MM, Mahapatra L, Aldawood A, Carpentieri DF, Chamlin SL, Kulungowski AM, Madan-Khetarpal S, Sebastian J, Pet MA, Coughlin CC, Willing MC, Pearson GD, Setty BA, El-Haffaf Z, Cottrell CE, Parikh BA, Krysiak K, Schroeder MC, Heusel JW, Neidich JA, Cao Y. A Comparative Analysis of RAS Variants in Patients with Disorders of Somatic Mosaicism. Genet Med. 2022 Nov 29;  

                


                  Setty BA, Wusik K, Hammill AM. How we approach genetics in the diagnosis and management of vascular anomalies. Pediatr Blood Cancer. 2022 Aug; 69 Suppl 3: e29320.

                


                  Koo SC, Schieffer KM, Lee K, Gupta A, Pfau RB, Avenarius MR, Stonerock E, LaHaye S, Fitch J, Setty BA, Roberts R, Ranalli M, Conces MR, Bu F, Mardis ER, Cottrell CE. EGFR internal tandem duplications in fusion-negative congenital and neonatal spindle cell tumors. Genes Chromosomes Cancer. 2022 Jul 7;  

                


                  de Souza Fernandez Pereira M, Carr DR, Gatti-Mays ME, Olsen MR, Setty BA, Shahwan KT, Lee DA. Natural Killer Cell Recognition and Control of Epithelial Cancers. Cancer J. 2022 Jul-Aug 01; 28: 263-269.

                


                  Pearson AD, Gaspar N, Janeway K, Campbell-Hewson Q, Lawlor ER, Copland C, Karres D, Norga K, Benzaghou F, Weiner S, Weigel B, Weiss AR, Strauss SJ, Smith M, Setty BA, Seibel N, Scobie N, Pappo A, Okpara CE, Nysom K, McDonough J, Marshall LV, Ludwinski D, Ligas F, Lesa G, Knudsen S, Kauh J, Hsieh A, Heenen D, Hawkins DS, Graham A, Garmey E, DuBois SG, Fox E, Donoghue M, de Rojas T, Chung J, Casanova M, Brennan B, Bishop M, Buenger V, Reaman G, Vassal G. Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. Eur J Cancer. 2022 Jul 18; 173: 71-90.

                


                  Fetzko S, Fonseca A, Frances Wedekind M, Gupta AA, Setty BA, Schraw J, Lupo PJ, Guillerman RP, Butala AA, Russell H, Nicholls L, Walterhouse D, Hawkins DS, Okcu MF. Is Detection of Relapse by Surveillance Imaging Associated With Longer Survival in Patients With Rhabdomyosarcoma? J Pediatr Hematol Oncol. 2022 Feb 9;  

                


                  Baliga S, Matsui J, Klamer B, Cetnar A, Ewing A, Cadieux C, Gupta A, Setty BA, Roberts RD, Olshefski RS, Cripe TP, Scharschmidt TJ, Aldrink J, Mardis E, Yeager ND, Palmer JD. Clinical outcomes and efficacy of stereotactic body radiation therapy in children, adolescents, and young adults with metastatic solid tumors. Br J Radiol. 2022 Feb 10;  20211088.

                


                  Halsey JN, Faith EF, Logan SJ, Shenoy A, Schieffer KM, Cottrell CE, Lillis AP, Aldrink JH, Setty BA, Pearson GD. Syringocystadenocarcinoma Papilliferum in a Fifteen-Year-Old Girl: A Case Report and Review of the Literature. Case Rep Dermatol Med. 2022; 2022: 8076649.

                


                  Merjaneh N, Young J, Mangoli A, Olsen M, Setty B, Lane A, Nagarajan R, Pressey JG, Turpin B. Chemotherapy-induced thrombocytopenia in Ewing sarcoma: Implications and potential for romiplostim supportive care. Pediatr Blood Cancer. 2021 Dec 28;  e29548.

                


                  LaHaye S, Fitch JR, Voytovich KJ, Herman AC, Kelly BJ, Lammi GE, Arbesfeld JA, Wijeratne S, Franklin SJ, Schieffer KM, Bir N, McGrath SD, Miller AR, Wetzel A, Miller KE, Bedrosian TA, Leraas K, Varga EA, Lee K, Gupta A, Setty B, Boué DR, Leonard JR, Finlay JL, Abdelbaki MS, Osorio DS, Koo SC, Koboldt DC, Wagner AH, Eisfeld AK, Mrózek K, Magrini V, Cottrell CE, Mardis ER, Wilson RK, White P. Discovery of clinically relevant fusions in pediatric cancer. BMC Genomics. 2021 Dec 4; 22: 872.

                


                  Perisa MP, Stanek J, Setty BA, Nicol K, Yeager N. Evaluating Age-related Disparity of Outcomes in Ewing Sarcoma Patients Treated at a Pediatric Academic Medical Center. J Pediatr Hematol Oncol. 2021 Jul 1; 43: e702-e706.

                


                  Osman AF, Setty BA. Case 3: Abdominal Distention, Shock, and Neonatal Encephalopathy. Neoreviews. 2021 Jun; 22: e406-e408.

                


                  Orr A, Liu H, Mariani R, Aldrink JH, Setty BA, Koo S. Bilateral Lung Metastases From a Phalangeal Giant Cell Tumor of Bone. Pediatr Dev Pathol. 2021 Jan-Feb; 24: 51-55.

                


                  Gupta A, Belsky JA, Schieffer KM, Leraas K, Varga E, McGrath SD, Koo SC, Magrini V, Wilson RK, White P, Mardis ER, Jatana KR, Cottrell CE, Setty BA. Infantile fibrosarcoma-like tumor driven by novel RBPMS-MET fusion consolidated with cabozantinib. Cold Spring Harb Mol Case Stud. 2020 Oct; 6: 

                


                  Belsky JA, Wolf K, Setty BA. A Case of Resolved Vincristine-Induced Constipation Following Osteopathic Medicine in a Patient With Infantile Fibrosarcoma. J Am Osteopath Assoc. 2020 Oct 1; 120: 691-695.

                


                  Oesterheld JE, Reed DR, Setty BA, Isakoff MS, Thompson P, Yin H, Hayashi M, Loeb DM, Smith T, Makanji R, Fridley BL, Wagner LM. Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation. Pediatr Blood Cancer. 2020 Jul; 67: e28370.

                


                  Setty BA, Jinesh GG, Arnold M, Pettersson F, Cheng CH, Cen L, Yoder SJ, Teer JK, Flores ER, Reed DR, Brohl AS. The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss. PLoS Genet. 2020 Apr; 16: e1008642.

                


                  Charan M, Dravid P, Cam M, Setty B, Roberts RD, Houghton PJ, Cam H. Tumor secreted ANGPTL2 facilitates recruitment of neutrophils to the lung to promote lung pre-metastatic niche formation and targeting ANGPTL2 signaling affects metastatic disease. Oncotarget. 2020 Feb 4; 11: 510-522.

                


                  Tullius BP, Setty BA, Lee DA. Natural Killer Cell Immunotherapy for Osteosarcoma. Adv Exp Med Biol. 2020; 1257: 141-154.

                


                  Streby KA, Currier MA, Triplet M, Ott K, Dishman DJ, Vaughan MR, Ranalli MA, Setty B, Skeens MA, Whiteside S, Yeager ND, Haworth KB, Simpson K, Conner J, Cripe TP. First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial. Mol Ther. 2019 Nov 6; 27: 1930-1938.

                


                  Patel P, Roberts R, Cole J, Stalling M, Nicol K, Hor K, Bowman J, Setty B. A Rare Case of an Intracardiac Myoepithelial Carcinoma in an Infant. J Pediatr Hematol Oncol. 2019 May; 41: e206-e209.

                


                  Shah N, Scharschmidt T, Fung B, Conces M, Setty BA. Aneursymal Bone Cyst: An Uncommon Paraspinal Tumor in Children. J Pediatr Hematol Oncol. 2019 Mar; 41: e129-e131.

                


                  Trucco M, Barredo JC, Goldberg J, Leclerc GM, Hale GA, Gill J, Setty B, Smith T, Lush R, Lee JK, Reed DR. A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG-asparaginase, and doxorubicin. Pediatr Blood Cancer. 2018 Sep; 65: e27224.

                


                  Setty BA, Stanek JR, Mascarenhas L, Miller A, Bagatell R, Okcu F, Nicholls L, Lysecki D, Gupta AA. VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma. Pediatr Blood Cancer. 2018 Jan; 65: 

                


                  Jacobson AE, Shah N, Setty BA. Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. Pediatr Blood Cancer. 2017 Aug; 64: 

                


                  Setty BA, Pillay Smiley N, Pool CM, Jin Y, Liu Y, Nelin LD. Hypoxia-induced proliferation of HeLa cells depends on epidermal growth factor receptor-mediated arginase II induction. Physiol Rep. 2017 Mar; 5: 

                


                  Audino AN, Setty BA, Yeager ND. Rhabdomyosarcoma of the Breast in Adolescent and Young Adult (AYA) Women. J Pediatr Hematol Oncol. 2017 Jan; 39: 62-66.

View More Publications

Interests

Complex Vascular Malformations Ewing Sarcoma Osteosarcoma Rhabdomyosarcoma

• Complex Vascular Malformations

• Ewing Sarcoma

• Osteosarcoma

• Rhabdomyosarcoma

• Abdelbaki MS, DeWire Schottmiller MD, Cripe TP, Curry RC, Cruze CA, Her L, Demko S, Casey D, Setty B. An open-label multi-center phase 1 safety study of BXQ-350 in children and young adults with relapsed solid tumors, including recurrent malignant brain tumors. Heliyon. 2022 Dec; 8: e12450.

• Hou YC, Evenson MJ, Corliss MM, Mahapatra L, Aldawood A, Carpentieri DF, Chamlin SL, Kulungowski AM, Madan-Khetarpal S, Sebastian J, Pet MA, Coughlin CC, Willing MC, Pearson GD, Setty BA, El-Haffaf Z, Cottrell CE, Parikh BA, Krysiak K, Schroeder MC, Heusel JW, Neidich JA, Cao Y. A Comparative Analysis of RAS Variants in Patients with Disorders of Somatic Mosaicism. Genet Med. 2022 Nov 29;

• Setty BA, Wusik K, Hammill AM. How we approach genetics in the diagnosis and management of vascular anomalies. Pediatr Blood Cancer. 2022 Aug; 69 Suppl 3: e29320.

• Koo SC, Schieffer KM, Lee K, Gupta A, Pfau RB, Avenarius MR, Stonerock E, LaHaye S, Fitch J, Setty BA, Roberts R, Ranalli M, Conces MR, Bu F, Mardis ER, Cottrell CE. EGFR internal tandem duplications in fusion-negative congenital and neonatal spindle cell tumors. Genes Chromosomes Cancer. 2022 Jul 7;

• de Souza Fernandez Pereira M, Carr DR, Gatti-Mays ME, Olsen MR, Setty BA, Shahwan KT, Lee DA. Natural Killer Cell Recognition and Control of Epithelial Cancers. Cancer J. 2022 Jul-Aug 01; 28: 263-269.

• Pearson AD, Gaspar N, Janeway K, Campbell-Hewson Q, Lawlor ER, Copland C, Karres D, Norga K, Benzaghou F, Weiner S, Weigel B, Weiss AR, Strauss SJ, Smith M, Setty BA, Seibel N, Scobie N, Pappo A, Okpara CE, Nysom K, McDonough J, Marshall LV, Ludwinski D, Ligas F, Lesa G, Knudsen S, Kauh J, Hsieh A, Heenen D, Hawkins DS, Graham A, Garmey E, DuBois SG, Fox E, Donoghue M, de Rojas T, Chung J, Casanova M, Brennan B, Bishop M, Buenger V, Reaman G, Vassal G. Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. Eur J Cancer. 2022 Jul 18; 173: 71-90.

• Fetzko S, Fonseca A, Frances Wedekind M, Gupta AA, Setty BA, Schraw J, Lupo PJ, Guillerman RP, Butala AA, Russell H, Nicholls L, Walterhouse D, Hawkins DS, Okcu MF. Is Detection of Relapse by Surveillance Imaging Associated With Longer Survival in Patients With Rhabdomyosarcoma? J Pediatr Hematol Oncol. 2022 Feb 9;

• Baliga S, Matsui J, Klamer B, Cetnar A, Ewing A, Cadieux C, Gupta A, Setty BA, Roberts RD, Olshefski RS, Cripe TP, Scharschmidt TJ, Aldrink J, Mardis E, Yeager ND, Palmer JD. Clinical outcomes and efficacy of stereotactic body radiation therapy in children, adolescents, and young adults with metastatic solid tumors. Br J Radiol. 2022 Feb 10; 20211088.

• Halsey JN, Faith EF, Logan SJ, Shenoy A, Schieffer KM, Cottrell CE, Lillis AP, Aldrink JH, Setty BA, Pearson GD. Syringocystadenocarcinoma Papilliferum in a Fifteen-Year-Old Girl: A Case Report and Review of the Literature. Case Rep Dermatol Med. 2022; 2022: 8076649.

• Merjaneh N, Young J, Mangoli A, Olsen M, Setty B, Lane A, Nagarajan R, Pressey JG, Turpin B. Chemotherapy-induced thrombocytopenia in Ewing sarcoma: Implications and potential for romiplostim supportive care. Pediatr Blood Cancer. 2021 Dec 28; e29548.

• LaHaye S, Fitch JR, Voytovich KJ, Herman AC, Kelly BJ, Lammi GE, Arbesfeld JA, Wijeratne S, Franklin SJ, Schieffer KM, Bir N, McGrath SD, Miller AR, Wetzel A, Miller KE, Bedrosian TA, Leraas K, Varga EA, Lee K, Gupta A, Setty B, Boué DR, Leonard JR, Finlay JL, Abdelbaki MS, Osorio DS, Koo SC, Koboldt DC, Wagner AH, Eisfeld AK, Mrózek K, Magrini V, Cottrell CE, Mardis ER, Wilson RK, White P. Discovery of clinically relevant fusions in pediatric cancer. BMC Genomics. 2021 Dec 4; 22: 872.

• Perisa MP, Stanek J, Setty BA, Nicol K, Yeager N. Evaluating Age-related Disparity of Outcomes in Ewing Sarcoma Patients Treated at a Pediatric Academic Medical Center. J Pediatr Hematol Oncol. 2021 Jul 1; 43: e702-e706.

• Osman AF, Setty BA. Case 3: Abdominal Distention, Shock, and Neonatal Encephalopathy. Neoreviews. 2021 Jun; 22: e406-e408.

• Orr A, Liu H, Mariani R, Aldrink JH, Setty BA, Koo S. Bilateral Lung Metastases From a Phalangeal Giant Cell Tumor of Bone. Pediatr Dev Pathol. 2021 Jan-Feb; 24: 51-55.

• Gupta A, Belsky JA, Schieffer KM, Leraas K, Varga E, McGrath SD, Koo SC, Magrini V, Wilson RK, White P, Mardis ER, Jatana KR, Cottrell CE, Setty BA. Infantile fibrosarcoma-like tumor driven by novel RBPMS-MET fusion consolidated with cabozantinib. Cold Spring Harb Mol Case Stud. 2020 Oct; 6:

• Belsky JA, Wolf K, Setty BA. A Case of Resolved Vincristine-Induced Constipation Following Osteopathic Medicine in a Patient With Infantile Fibrosarcoma. J Am Osteopath Assoc. 2020 Oct 1; 120: 691-695.

• Oesterheld JE, Reed DR, Setty BA, Isakoff MS, Thompson P, Yin H, Hayashi M, Loeb DM, Smith T, Makanji R, Fridley BL, Wagner LM. Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation. Pediatr Blood Cancer. 2020 Jul; 67: e28370.

• Setty BA, Jinesh GG, Arnold M, Pettersson F, Cheng CH, Cen L, Yoder SJ, Teer JK, Flores ER, Reed DR, Brohl AS. The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss. PLoS Genet. 2020 Apr; 16: e1008642.

• Charan M, Dravid P, Cam M, Setty B, Roberts RD, Houghton PJ, Cam H. Tumor secreted ANGPTL2 facilitates recruitment of neutrophils to the lung to promote lung pre-metastatic niche formation and targeting ANGPTL2 signaling affects metastatic disease. Oncotarget. 2020 Feb 4; 11: 510-522.

• Tullius BP, Setty BA, Lee DA. Natural Killer Cell Immunotherapy for Osteosarcoma. Adv Exp Med Biol. 2020; 1257: 141-154.

• Streby KA, Currier MA, Triplet M, Ott K, Dishman DJ, Vaughan MR, Ranalli MA, Setty B, Skeens MA, Whiteside S, Yeager ND, Haworth KB, Simpson K, Conner J, Cripe TP. First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial. Mol Ther. 2019 Nov 6; 27: 1930-1938.

• Patel P, Roberts R, Cole J, Stalling M, Nicol K, Hor K, Bowman J, Setty B. A Rare Case of an Intracardiac Myoepithelial Carcinoma in an Infant. J Pediatr Hematol Oncol. 2019 May; 41: e206-e209.

• Shah N, Scharschmidt T, Fung B, Conces M, Setty BA. Aneursymal Bone Cyst: An Uncommon Paraspinal Tumor in Children. J Pediatr Hematol Oncol. 2019 Mar; 41: e129-e131.

• Trucco M, Barredo JC, Goldberg J, Leclerc GM, Hale GA, Gill J, Setty B, Smith T, Lush R, Lee JK, Reed DR. A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG-asparaginase, and doxorubicin. Pediatr Blood Cancer. 2018 Sep; 65: e27224.

• Setty BA, Stanek JR, Mascarenhas L, Miller A, Bagatell R, Okcu F, Nicholls L, Lysecki D, Gupta AA. VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma. Pediatr Blood Cancer. 2018 Jan; 65:

• Jacobson AE, Shah N, Setty BA. Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. Pediatr Blood Cancer. 2017 Aug; 64:

• Setty BA, Pillay Smiley N, Pool CM, Jin Y, Liu Y, Nelin LD. Hypoxia-induced proliferation of HeLa cells depends on epidermal growth factor receptor-mediated arginase II induction. Physiol Rep. 2017 Mar; 5:

• Audino AN, Setty BA, Yeager ND. Rhabdomyosarcoma of the Breast in Adolescent and Young Adult (AYA) Women. J Pediatr Hematol Oncol. 2017 Jan; 39: 62-66.

Education

Date of Appointment at Nationwide Children’s Hospital: 01/28/2011

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2011

Residency

University of Illinois Medical Center at Chicago

Date Completed: 06/30/2008

Medical School

BLDEA’s Shri B M Patil Medical College

Date Completed: 08/30/2003

Education

Date of Appointment at Nationwide Children’s Hospital: 01/28/2011

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2011

Residency

University of Illinois Medical Center at Chicago

Date Completed: 06/30/2008

Medical School

BLDEA’s Shri B M Patil Medical College

Date Completed: 08/30/2003

Education

Date of Appointment at Nationwide Children’s Hospital: 01/28/2011

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2011

Residency

University of Illinois Medical Center at Chicago

Date Completed: 06/30/2008

Medical School

BLDEA’s Shri B M Patil Medical College

Date Completed: 08/30/2003

Date of Appointment at Nationwide Children’s Hospital: 01/28/2011

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2011

Residency

University of Illinois Medical Center at Chicago

Date Completed: 06/30/2008

Medical School

BLDEA’s Shri B M Patil Medical College

Date Completed: 08/30/2003

Date of Appointment at Nationwide Children’s Hospital: 01/28/2011

Board Certifications

Pediatric Hematology Oncology Pediatrics

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2011

Residency

University of Illinois Medical Center at Chicago

Date Completed: 06/30/2008

Medical School

BLDEA’s Shri B M Patil Medical College

Date Completed: 08/30/2003

• Pediatric Hematology Oncology
• Pediatrics

Clinical Interests

Complex Vascular Anomalies Ewing Sarcoma Lymphatic Malformations Non Rhabdomyosarcoma Soft Tissue Tumors Osteosarcoma Rhabdomyosarcoma Venous Malformations

Clinical Interests

Complex Vascular Anomalies Ewing Sarcoma Lymphatic Malformations Non Rhabdomyosarcoma Soft Tissue Tumors Osteosarcoma Rhabdomyosarcoma Venous Malformations

Clinical Interests

Complex Vascular Anomalies Ewing Sarcoma Lymphatic Malformations Non Rhabdomyosarcoma Soft Tissue Tumors Osteosarcoma Rhabdomyosarcoma Venous Malformations

Complex Vascular Anomalies Ewing Sarcoma Lymphatic Malformations Non Rhabdomyosarcoma Soft Tissue Tumors Osteosarcoma Rhabdomyosarcoma Venous Malformations

• Complex Vascular Anomalies
• Ewing Sarcoma
• Lymphatic Malformations
• Non Rhabdomyosarcoma Soft Tissue Tumors
• Osteosarcoma
• Rhabdomyosarcoma
• Venous Malformations

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

• Call us at:
• (614) 722-3550
• Fax us at:
• (614) 722-3369
• Hematology & Oncology700 Children’s DrColumbus, OH 43205 (map)